INVENTIA

Live / Registered — Registered (as of 20 Jan 2026)

What this means for you

Registered since 20 Jan 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 20 Jan 2032: the §71 affidavit of use).

Record

Serial number
79385808
Registration number
8105499
Mark type
Word mark
Filed
14 Jul 2023
Published for opposition
02 Dec 2025
Registered
20 Jan 2026
Next maintenance filing
§71 affidavit of use, due by 20 Jan 2032 (grace period to 20 Jul 2032)
Attorney of record
Robyn S. Lederman

Goods and services

  • Class 007 — Machines and machine tools: 3D printers; computerized printers for the generation of 3D shaped parts; machines, namely, 3D bioprinters for the printing of living cells and tissues or printing 3D cell structures; cartridges being parts of 3D printers for containing printing materials; cartridges being parts of 3D printers for containing bioprinting materials; printing cartridges being parts of 3D printers for containing biomaterials and reagents; printing cartridges being parts of 3D printers for containing bio-ink; robotic handling apparatus, namely, robotic handling apparatus and arms for industrial and commercial use; accessories and spare parts for three dimensional (3D) printers for the production of biological materials, namely, print heads for three dimensional (3D) printers; machines, namely, three dimensional (3D) printer for the printing of engineered living tissues; three dimensional (3D) printers; structural parts and fittings therefor * ; none of the foregoing being in relation to oral or injectable therapies for the treatment of patient needs in the areas of fibrosis, lysosomal storage disorders and oncology, cardiometabolic diseases, liver diseases, metabolic disorders (including obesity, diabetes, severe dyslipidemias, NASH), inflammatory diseases and autoimmune diseases *
  • Class 009 — Scientific and electric apparatus: Laboratory robots; downloadable software for monitoring and controlling communication between computers and automated machine systems; downloadable software for operating and controlling 3D printers; downloadable operating software to control laboratory apparatus for fabrication of three dimensional (3D) engineered living tissues; downloadable software for the purpose of the manufacture of products by means of a 3D printer, including medical products; laboratory instruments and apparatus, namely, cell assembly apparatus for laboratory use for fabrication of three dimensional (3D) engineered living tissues; print heads for 3D printers and bioprinters; downloadable electronic publications, namely, pamphlets, brochures, journals, books, manuals, newsletters and booklets in the field of living tissue, tissue regeneration, 3D printing, cell printing, cell assembly and biomedical research; parts and fittings for all of the foregoing, namely, electronic control panels with digital displays for the control of three dimensional (3D) printers, printer cables, and ink cartridges, unfilled, for printers * ; none of the foregoing being in relation to oral or injectable therapies for the treatment of patient needs in the areas of fibrosis, lysosomal storage disorders and oncology, cardiometabolic diseases, liver diseases, metabolic disorders (including obesity, diabetes, severe dyslipidemias, NASH), inflammatory diseases and autoimmune diseases *
  • Class 010 — Medical apparatus: Surgical robots, namely, robotic apparatus for medical or surgical purposes; surgical robots; surgical robots for medical purposes; medical apparatus for use in soft tissue repair, reconstruction of soft tissue deficiencies, regenerative surgery, plastic reconstructive surgery and wound healing in the field of living tissue, tissue regeneration, 3D printing, bioprinting, cell printing, cell assembly and biomedical research; structural parts and fittings therefor; none of the foregoing being in relation to oral or injectable therapies for the treatment of patient needs in the areas of fibrosis, lysosomal storage disorders and oncology, cardiometabolic diseases, liver diseases, metabolic disorders, obesity, diabetes, severe dyslipidemias, NASH, inflammatory diseases and autoimmune diseases
  • Class 035 — Advertising and business services: Data management; wholesale and retail store services for pharmaceutical, medical, scientific, laboratory and 3D printing consumables and supplies; online wholesale and retail store services featuring pharmaceutical, medical, scientific, laboratory and 3D printing consumables and supplies; administrative processing of purchase orders; order fulfillment services, namely, computerised stock ordering and purchasing; computerised data processing; compiling and analyzing statistics, data and other sources of scientific information for business purposes; computerised register management, namely, maintenance of registers for others * none of the foregoing being in relation to oral or injectable therapies for the treatment of patient needs in the areas of fibrosis, lysosomal storage disorders and oncology, cardiometabolic diseases, liver diseases, metabolic disorders (including obesity, diabetes, severe dyslipidemias, NASH), inflammatory diseases and autoimmune diseases *
  • Class 042 — Scientific and technological services: Scientific and technological services and research and design relating thereto, all in the field of living tissue, tissue regeneration, 3D printing, bioprinting, cell printing, cell assembly and biomedical research; industrial analysis, industrial research and industrial design services, all in the field of living tissue, tissue regeneration, 3D printing, bioprinting, cell printing, cell assembly and biomedical research; design and development of computer software; software as a service (SAAS) services, namely, hosting software for use by others in the field of living tissue, tissue regeneration, 3D printing, bioprinting, cell printing, cell assembly and biomedical research and to identify, select and print biomaterials for the purpose of experiments; providing online non-downloadable software for use by others in the field of living tissue, tissue regeneration, 3D printing, bioprinting, cell printing, cell assembly and biomedical research and to identify, select and print biomaterials for the purpose of experiments; computer support services, namely, computer programming and software installation, repair and maintenance services; scientific research services, specifically, analysis of statistical data for scientific research purposes; design of software; design and development of new products in the field of biological materials; visual design services in the nature of designing visual elements for print media; new product design services; scientific research relating to design in the field of 3D printing, bioprinting, cell printing, cell assembly and biomedical research; laboratory research in the field of biomedical research, bioprinting, cell printing, cell assembly and the creation and engineering of 3D cells and living tissues; biomedical research; cloud computing featuring software for use in the field of living tissue, tissue regeneration, 3D printing, bioprinting, cell printing, cell assembly and biomedical research and to identify, select and print biomaterials for the purpose of experiments; technical consultancy in the field of scientific research; scientific research in the field of soft tissue repair, reconstruction of soft tissue deficiencies, regenerative surgery, plastic reconstructive surgery, wound healing, drug discovery, genetics, dermatology and oncology; scientific research into the development of new products; technical support services, namely, troubleshooting in the nature of repair of medical equipment and diagnostic laboratory instruments and systems; providing online non-downloadable web-based computer software platforms for laboratory and diagnostic equipment information management, monitoring and analysis; providing information and online information regarding the foregoing; none of the foregoing being in relation to oral or injectable therapies for the treatment of patient needs in the areas of fibrosis, lysosomal storage disorders and oncology, cardiometabolic diseases, liver diseases, metabolic disorders (including obesity, diabetes, severe dyslipidemias, NASH), inflammatory diseases and autoimmune diseases

Owner

Prosecution history

  • 16 Oct 2026 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
  • 03 Sept 2026 — FINAL DECISION TRANSACTION PROCESSED BY IB
  • 20 Aug 2026 — NEW REPRESENTATIVE AT IB RECEIVED
  • 23 Jul 2026 — FINAL DISPOSITION NOTICE SENT TO IB
  • 23 Jul 2026 — FINAL DISPOSITION PROCESSED
  • 07 Jul 2026 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
  • 17 Jun 2026 — LIMITATION FROM THE IB EXAMINED AND ENTERED
  • 17 Jun 2026 — CORRECTION UNDER SECTION 7 - PROCESSED
  • 17 Jun 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 20 Apr 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
  • 20 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 20 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
  • 25 Dec 2025 — LIMITATION OF GOODS RECEIVED FROM IB
  • 11 Dec 2025 — NOTIFICATION PROCESSED BY IB
  • 02 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

View this trademark record on Rightsy